BIOCRITICA, INC.

Profile

Company Names

BIOCRITICA, INC.

Addresses

8888 KEYSTONE CROSSING, SUITE 1300, INDIANAPOLIS, IN 46240

Phone Numbers

317-575-4035

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2011

State Incorporated:

DELAWARE

Total Amount Raised:

$25,000,000.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2011-05-20 
$25,000,000.00 
$25,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MICHAEL 
 
BOLOGNA 
DIRECTOR
BIOCRITICA, INC.   |  NOVAQUEST PHARMA OPPORTUNITIES FUND VI, L.P.
DAVID 
A. 
BROECKER 
EXECUTIVE OFFICER, DIRECTOR
BIOCRITICA, INC.   |  ZORION MEDICAL, INC.
DARREN 
 
CARROLL 
DIRECTOR
GLOBEIMMUNE INC   |  BIOCRITICA, INC.   |  POLARIS PARTNERS X, L.P.
MIKE 
F. 
JOHNSON 
DIRECTOR
BIOCRITICA, INC.
ARGERIS 
N. 
KARABELAS 
DIRECTOR
BIOCRITICA, INC.
MICHAEL 
 
PAGNOTTA 
EXECUTIVE OFFICER
BIOCRITICA, INC.
LORENZO 
 
PELLEGRINI 
DIRECTOR
AGILE THERAPEUTICS INC   |  BIOCRITICA, INC.   |  PALLADIO BIOSCIENCES, INC.   |  HATCH BIOFUND, LP
MARK 
D. 
WILLIAMS 
EXECUTIVE OFFICER
BIOCRITICA, INC.
RONALD 
J. 
WOOTEN 
DIRECTOR
QUINTILES TRANSNATIONAL HOLDINGS INC.   |  BIOCRITICA, INC.   |  NOVAQUEST PHARMA OPPORTUNITIES FUND III, L.P.   |  NOVAQUEST CO-INVESTMENT FUND I, L.P.   |  NOVAQUEST PRIVATE EQUITY FUND I, L.P.   |  NQ PE PROJECT KIT, L.P.   |  NQ PE PROJECT INCA (PARENT), L.P.   |  NQ PE PROJECT INCA, L.P.   |  NQ PE PROJECT CONSTELLATION, L.P.   |  NOVAQUEST ANIMAL HEALTH OPPORTUNITIES FUND, L.P.   |  NOVAQUEST ANIMAL HEALTH OPPORTUNITIES FUND (DELAWARE), L.P.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2011-05-26
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2011-05-20 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#